Taubert Jennifer L (CIK 1745938) reported 12 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-18). Recent activity: Buy JNJ (15,000 shares), Sell JNJ (15,000 shares), Buy JNJ (1,302 shares), Sell JNJ (409 shares), Buy JNJ (27,412 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-18 | JOHNSON & JOHNSON (JNJ) | EVP, WWC. Innovative Medicine | Buy | 15,000 | $1.7M |
| 2026-08-18 | JOHNSON & JOHNSON (JNJ) | EVP, WWC. Innovative Medicine | Sell | 15,000 | $4.0M |
| 2026-02-18 | JOHNSON & JOHNSON (JNJ) | EVP, WWC. Innovative Medicine | Buy | 1,302 | $0 |
| 2026-02-18 | JOHNSON & JOHNSON (JNJ) | EVP, WWC. Innovative Medicine | Sell | 409 | $100,021 |
| 2026-02-18 | JOHNSON & JOHNSON (JNJ) | EVP, WWC. Innovative Medicine | Buy | 27,412 | $0 |
| 2026-02-18 | JOHNSON & JOHNSON (JNJ) | EVP, WWC. Innovative Medicine | Sell | 13,547 | $3.3M |
| 2026-02-18 | JOHNSON & JOHNSON (JNJ) | EVP, WWC. Innovative Medicine | Buy | 1,594 | $0 |
| 2026-02-18 | JOHNSON & JOHNSON (JNJ) | EVP, WWC. Innovative Medicine | Sell | 816 | $198,655 |
| 2026-02-18 | JOHNSON & JOHNSON (JNJ) | EVP, WWC. Innovative Medicine | Buy | 1,847 | $0 |
| 2026-02-18 | JOHNSON & JOHNSON (JNJ) | EVP, WWC. Innovative Medicine | Sell | 945 | $230,060 |
| 2025-09-05 | JOHNSON & JOHNSON (JNJ) | EVP, WWC. Innovative Medicine | Buy | 56,471 | $5.8M |
| 2025-09-05 | JOHNSON & JOHNSON (JNJ) | EVP, WWC. Innovative Medicine | Sell | 56,471 | $10.0M |
Source: SEC Form 4 filings · as of 2026-08-18